Xtalpi Inc. Partners with Gnosis Neurodynamics to Develop Neural Drug Screening Platform
Shenzhen-based QuantumPharm Inc., trading as Xtalpi Inc. (HKG: 2228), has announced a strategic partnership with...
Shenzhen-based QuantumPharm Inc., trading as Xtalpi Inc. (HKG: 2228), has announced a strategic partnership with...
Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic...
Chengdu-based, generative artificial intelligence (AI)-driven clinical stage biotech company, Insilico Medicine, has announced the receipt...
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has formed two multi-program strategic partnerships with compatriot...
US-based biotech AI Proteins, Inc. has entered into a research collaboration and option agreement with...
China-based YiChang HEC ChangJiang Pharmaceutical Co., Ltd (HKG: 1558) has announced a comprehensive partnership with...
China-based Fangzhou Inc. (HKG: 6086) hosted the “Data and AI: Decoding Digital Engagement” summit in...
China’s generative artificial intelligence (AI)-driven biotech company, Insilico Medicine, has announced that it has received...
Merck KGaA (NYSE: MRK) has entered into a Memorandum of Understanding with the Digital Trust...
Shanghai-based United Imaging Healthcare Co., Ltd. has announced the installation of an ultra-wide-bore AI-empowered uMR...
Apeiron Therapeutics, a biomarker-driven cancer therapy developer with operations in Shanghai, China, and San Francisco,...
The National Health Commission, National Administration of Traditional Chinese Medicine, and National Bureau of Disease...
China-based artificial intelligence (AI) drug developer Insilico Medicine has announced the establishment of a Revolving...
UK pharmaceutical giant GSK plc (LON: GSK, NYSE: GSK) has unveiled a significant five-year partnership...
The Affiliated Hospital of Xuzhou Medical University has entered into a comprehensive partnership with Huawei...
Eli Lilly & Co. (NYSE: LLY), a stalwart of the US pharmaceutical industry, has inked...
XtalPi (QuantumPharm, HKG: 2228) a leading AI-driven drug discovery firm based in Shenzhen and known...
Insilico Medicine has announced a strategic partnership with Seto Bio (SHE: 300583) to harness cutting-edge...
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the...
China-based artificial intelligence (AI) drug developer Insilico Medicine has reported initial positive data from its...